Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
22,618
Period ended Dec 31, 2025
Change on a year earlier
+17.5%
19,246 in FY2024
History
20 years
Since FY2006
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total stockholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22,618 | +17.5% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 19,246 | -15.4% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 22,749 | +7.3% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 21,209 | +0.7% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 21,064 | +15.6% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 18,221 | -19.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 22,650 | +5.2% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 21,534 | +5.0% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 20,501 | +5.9% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 19,363 | +1.3% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 19,113 | +20.8% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 15,819 | +34.7% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 11,745 | +23.1% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 9,544 | +39.0% | Form 10-K (filed 2015-02-25) ↗ |
| FY2011 | Dec 31, 2011 | 6,867 | +12.2% | Form 10-K (filed 2015-02-25) ↗ |
| FY2010 | Dec 31, 2010 | 6,122 | -5.9% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 6,505 | +45.7% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 4,466 | +19.0% | Form 10-Q (filed 2009-08-05) ↗ |
| FY2007 | Dec 31, 2007 | 3,753 | +82.9% | Form 10-K (filed 2010-03-01) ↗ |
| FY2006 | Dec 31, 2006 | 2,052 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total stockholders' equity ($M) ($M), annual FY2006–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_eq
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.